<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T15:57:40Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10230/72116" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10230/72116</identifier><datestamp>2025-12-05T15:20:43Z</datestamp><setSpec>com_2072_6</setSpec><setSpec>col_2072_452952</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2025-12-05T15:20:43Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_10230_72116">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10230/72116</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence</dc:title>
               <dc:creator>Merino, Jana</dc:creator>
               <dc:creator>Planas, Adriana</dc:creator>
               <dc:creator>Moner, Ana de</dc:creator>
               <dc:creator>Gasol, Ana</dc:creator>
               <dc:creator>Contreras, Carmen</dc:creator>
               <dc:creator>Vidal-Barraquer, Francesc</dc:creator>
               <dc:creator>Marrugat de la Iglesia, Jaume</dc:creator>
               <dc:creator>Clará Velasco, Alberto</dc:creator>
               <dc:subject>Cardiovascular diseases</dc:subject>
               <dc:subject>Risk factors</dc:subject>
               <dc:subject>Cohort studies</dc:subject>
               <dc:subject>Peripheral vascular diseases</dc:subject>
               <dc:subject>Coronary disease</dc:subject>
               <dc:description>Objectives: The association of peripheral arterial occlusive disease (PAD) association with major coronary events (MCE) has been well documented, nevertheless data are lacking for populations with a low incidence of coronary heart disease (CHD). We aimed to assess the association of PAD with MCE in a Mediterranean population. Design: Prospective survey of 699 55-74 year-old men representative of an urban district near Barcelona (Spain). Methods: Baseline cardiovascular risk factors, CHD and PAD (ankle/brachial index&lt;0.9) were recorded. MCE were evaluated during the 5-year follow-up. Results: At recruitment 94 subjects (13.4%) had PAD. During follow-up (mean 69.3 months), 35 (5%) subjects suffered a MCE, of whom 12 had PAD, 9 previous symptomatic CHD and 1 subject both conditions. Higher CHD related mortality (8.6% vs 1.4%; p&lt;0.001) and lower MCE-free survival (78.67% vs 93.26%; p&lt;0.001) was observed for PAD subjects. On Cox regression analysis PAD (RR=3; p=0.003) and previous symptomatic CHD (RR=4.1; p&lt;0.001) were associated independently with MCE during follow-up. Conclusions: Even in a population with a low incidence of CHD there is a strong relationship between PAD and future MCE. Screening for PAD may improve the selection of patients targeted for cardiovascular risk prevention.</dc:description>
               <dc:date>2025-12-05T15:20:43Z</dc:date>
               <dc:date>2025-12-05T15:20:43Z</dc:date>
               <dc:date>2025-12-03T14:48:20Z</dc:date>
               <dc:date>2025-12-03T14:48:20Z</dc:date>
               <dc:date>2008</dc:date>
               <dc:date>2025-12-03T14:48:20Z</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/10230/72116</dc:identifier>
               <dc:relation>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery.  2008;36(1):71-6. DOI: 10.1016/j.ejvs.2008.01.029</dc:relation>
               <dc:rights>© Elsevier http://dx.doi.org/10.1016/j.ejvs.2008.01.029</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>Elsevier</dc:publisher>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>